サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1641769

不妊・妊娠迅速検査キットの世界市場：製品別、検査タイプ別、エンドユーザー別 - 機会分析と産業予測、2024年～2033年

Fertility and Pregnancy Rapid Test Kits Market By Product , By Test Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 240 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
不妊・妊娠迅速検査キットの世界市場：製品別、検査タイプ別、エンドユーザー別 - 機会分析と産業予測、2024年～2033年
出版日: 2024年11月01日
発行: Allied Market Research
ページ情報: 英文 240 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

不妊・妊娠迅速検査キット市場は、2023年に15億米ドルとなり、2024年から2033年にかけてCAGR7.4％で成長し、2033年までには31億米ドルに達すると予測されています。

Fertility and Pregnancy Rapid Test Kits Market-IMG1

不妊・妊娠迅速検査キットは、女性の不妊状態や妊娠を示す尿や唾液中のホルモンを迅速に検出するように設計された市販の診断ツールです。これらの検査は、個人がヘルスケア専門家の介入を必要とせずに生殖の健康をモニターする便利でプライベートな方法を提供します。妊娠検査キットは、妊娠中に産生されるホルモンであるヒト絨毛性ゴナドトロピンの存在を検出し、不妊検査キットは排卵に重要な黄体形成ホルモンやエストロゲンを検出します。

世界の不妊・妊娠迅速検査キット市場は、リプロダクティブ・ヘルス（生殖に関する健康）に対する意識の高まりや、特に妊娠を希望する人々の間で、自宅で検査ができる利便性などの要因により、堅調な成長を遂げています。加えて、ライフスタイル要因や出産の遅れによる不妊率の憂慮すべき上昇が、妊娠を希望するカップルの間で不妊検査キットへのニーズを高めています。世界保健機関（WHO）が本日発表した2023年の調査によると、成人人口の約17.5％が不妊を経験しています。2024年の不妊統計では、世界全体で4,850万組のカップルが不妊を経験していることが明らかになりました。このことは、個人が不妊サイクルをモニターし、十分な情報に基づいた意思決定を行うための不妊検査キットの緊急の必要性を浮き彫りにしています。さらに、不妊・妊娠迅速検査キットは比較的安価であるため、頻繁に医師の診察を受けることなく生殖機能をモニターしようとする個人にとって手頃な選択肢となり、市場成長を大きく牽引しています。さらに、これらのキットは実店舗やオンライン・マーケットプレースの両方で広く販売されているため、消費者が簡単に入手でき、市場成長に寄与しています。妊娠の早期発見、特に不規則な周期の女性や妊娠を迅速に確認したい女性は、妊娠検査キットの需要をさらに増大させています。進歩にもかかわらず、検査キットの中には偽陽性や偽陰性を示すものもあり、これが市場成長の大きな妨げとなっています。さらに、より詳細な洞察を提供するデジタル排卵トラッカーやモバイルアプリなど、他の生殖医療技術の台頭は、従来の検査キットの需要を減少させ、市場成長を抑制する可能性があります。これとは反対に、より高い精度、ユーザーフレンドリーなデザイン、より迅速な結果など、検査キット技術の革新は、これらの製品の魅力と信頼性を拡大しており、予測期間中に世界市場の拡大に有益な機会を提供すると期待されています。さらに、計画外妊娠の負担の増加や中絶率の憂慮すべき上昇により、予防措置としての妊娠検査に関する認識を高めるための政府の取り組みが、今後数年間の市場成長に新たな道を開くと予想されます。World Family Planningが発表した2022年の調査によると、41カ国の女性の約50％が妊娠を防ぐために避妊具を使用しています。そのうち22カ国はサハラ以南のアフリカ諸国です。

世界の不妊・妊娠迅速検査キット市場は、製品、検査タイプ、エンドユーザー、地域に区分されます。製品別では、市場は妊娠迅速検査キットと不妊迅速検査キットに二分されます。検査タイプ別では、尿ベースの検査キットと血液ベースの検査キットに分類されます。エンドユーザー別では、病院、在宅医療現場、その他に分けられます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカで分析されます。

主な調査結果

製品別では、妊娠迅速検査分野が2024年から2033年にかけて市場を独占すると予測されます。

検査タイプ別では、尿検査キット迅速検査分野が予測期間中に最も高い成長を示すと予測されます。

エンドユーザー別では、予測期間中、在宅医療分野が顕著なペースで成長すると予測されます。

地域別では、不妊・妊娠迅速検査キット市場は今後数年間、北米で力強い成長が見込まれます。

本レポートはカスタマイズが可能です。（追加費用とスケジュールがあります。）

  • 新製品開発/主要企業の製品マトリックス
  • 規制ガイドライン
  • 顧客の関心に応じた追加企業プロファイル
  • 国別または地域別追加分析-市場規模と予測
  • 平均販売価格分析／価格帯分析
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要企業の詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要な調査結果
    • 主要な投資機会
    • 主要な成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 不妊・妊娠迅速検査キット市場：製品別

  • 市場概要
  • 妊娠迅速検査キット
  • 受胎可能性迅速検査キット

第5章 不妊・妊娠迅速検査キット市場：検査タイプ別

  • 市場概要
  • 尿検査キット
  • 血液検査キット
  • その他

第6章 不妊・妊娠迅速検査キット市場：エンドユーザー別

  • 市場概要
  • 病院
  • 在宅医療
  • その他

第7章 不妊・妊娠迅速検査キット市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の不妊・妊娠迅速検査キット市場
    • カナダの不妊・妊娠迅速検査キット市場
    • メキシコの不妊・妊娠迅速検査キット市場
  • 欧州
    • 主な市場動向と機会
    • ドイツの不妊・妊娠迅速検査キット市場
    • フランスの不妊・妊娠迅速検査キット市場
    • 英国の不妊・妊娠迅速検査キット市場
    • イタリアの不妊・妊娠迅速検査キット市場
    • スペインの不妊・妊娠迅速検査キット市場
    • その他欧州の不妊・妊娠迅速検査キット市場
  • アジア太平洋
    • 主な市場動向と機会
    • 日本の不妊・妊娠迅速検査キット市場
    • 中国の不妊・妊娠迅速検査キット市場
    • インドの不妊・妊娠迅速検査キット市場
    • オーストラリア不妊・妊娠迅速検査キット市場
    • 韓国の不妊・妊娠迅速検査キット市場
    • その他アジア太平洋の不妊・妊娠迅速検査キット市場
  • ラテンアメリカ、中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの不妊・妊娠迅速検査キット市場
    • サウジアラビアの不妊・妊娠迅速検査キット市場
    • 南アフリカの不妊・妊娠迅速検査キット市場
    • その他のラテンアメリカ、中東・アフリカの不妊・妊娠迅速検査キット市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2023年

第9章 企業プロファイル

  • Atlas Medical GmbH
  • Church And Dwight Co., Inc.
  • Everlywell, Inc.
  • Geratherm Medical AG
  • QuidelOrtho Corporation
  • Mylab Discovery Solutions Pvt. Ltd.
  • Salignostics
  • Abbott
  • SPD Swiss Precision Diagnostics GmbH
  • AdvaCare Pharma
目次
Product Code: A324421

The fertility and pregnancy rapid test kits market was valued at $1.5 billion in 2023, and is projected to reach $3.1 billion by 2033, growing at a CAGR of 7.4% from 2024 to 2033.

Fertility and Pregnancy Rapid Test Kits Market - IMG1

Fertility and pregnancy rapid test kits are over-the-counter diagnostic tools designed to quickly detect hormones in urine or saliva that indicate a woman's fertility status or pregnancy. These tests provide a convenient and private way for individuals to monitor their reproductive health without the need for a healthcare professional's intervention. Pregnancy test kits detect the presence of human chorionic gonadotropin, a hormone produced during pregnancy, while fertility test kits detect luteinizing hormone or estrogen, which are critical for ovulation.

The global fertility and pregnancy rapid test kits market is witnessing robust growth due to factors such as rise in awareness about reproductive health and the convenience of at-home testing, especially among individuals trying to conceive. In addition, alarming rise in infertility rates due to lifestyle factors and delayed childbearing is driving a greater need for fertility test kits among couples seeking to conceive. According to a study published today by the World Health Organization in 2023, around 17.5% of the adult population experience infertility. The Infertility Statistics 2024 revealed that 48.5 million couples experience infertility globally. This highlights the urgent need for fertility test kits to help individuals monitor their fertility cycles and make informed decision. Moreover, the market growth is significantly driven by the relatively low cost of fertility and pregnancy rapid test kits makes them an affordable option for individuals seeking to monitor their reproductive health without the expense of frequent doctor visits. Furthermore, the widespread availability of these kits in both physical retail stores and online marketplaces makes them easy for consumers to access, thus contributing to the market growth. Early detection of pregnancy, especially for women with irregular cycles or those who want to confirm pregnancy quickly, is further augmenting the demand for pregnancy test kits. Despite advancements, some test kits may still provide false positives or false negatives, which significantly hampers the market growth. In addition, rise of other reproductive health technologies, such as digital ovulation trackers or mobile apps that offer more detailed insights, may reduce the demand for traditional test kits, thereby restraining the market growth. On the contrary, innovations in test kit technology, including greater accuracy, user-friendly designs, and faster results, have expanded the appeal and reliability of these products, which are expected to offer remunerative opportunities for the expansion of the global market during the forecast period. In addition, government initiatives to increase awareness about pregnancy testing as a preventative measure due to rise in burden of unplanned pregnancies and alarming rise in rate of abortion are anticipated to open new avenues for the growth of the market in the coming years. According to a 2022 study published by the World Family Planning, approximately 50% of the women across 41 countries use contraceptives to prevent pregnancy. Among these, 22 countries were from sub-Saharan Africa alone.

The global fertility and pregnancy rapid test kits market is segmented into product, test type, end user, and region. On the basis of the product, the market is bifurcated into pregnancy rapid tests and fertility rapid tests. By test type, it is classified into urine-based test kits and blood-based test kits. Depending on end user, it is divided into hospitals, homecare settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the pregnancy rapid tests segment is expected to dominate the market from 2024 to 2033.

On the basis of test type, the urine-based test kits rapid tests segment is anticipated to exhibit the highest growth during the forecast period.

Depending on end user, the homecare settings segment is projected to grow at a notable pace throughout the forecast period.

Region wise, the fertility and pregnancy rapid test kits market is likely to witness strong growth in In North America in the coming years.

Competition Analysis

Competitive analysis and profiles of the major players in the global fertility and pregnancy rapid test kits market include Atlas Medical GmbH, Church & Dwight Co., Inc., Everlywell, Inc., Geratherm Medical AG, QuidelOrtho Corporation, Mylab Discovery Solutions Pvt. Ltd., Salignostics , Abbott, SPD Swiss Precision Diagnostics GmbH, and AdvaCare Pharma. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Pregnancy Rapid Tests
  • Fertility Rapid Tests

By Test Type

  • Urine-based Test Kits
  • Blood-based Test Kits
  • Others

By End User

  • Hospitals
  • Homecare Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Atlas Medical GmbH
    • Church & Dwight Co., Inc.
    • Everlywell, Inc.
    • Geratherm Medical AG
    • QuidelOrtho Corporation
    • Mylab Discovery Solutions Pvt. Ltd.
    • Salignostics
    • Abbott
    • SPD Swiss Precision Diagnostics GmbH
    • AdvaCare Pharma

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Pregnancy Rapid Tests
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Fertility Rapid Tests
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY TEST TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Test Type
  • 5.2. Urine-based Test Kits
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Blood-based Test Kits
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Homecare Settings
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Test Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Fertility and Pregnancy Rapid Test Kits Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Test Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Fertility and Pregnancy Rapid Test Kits Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Test Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Fertility and Pregnancy Rapid Test Kits Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Test Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Test Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Test Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Test Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Test Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Test Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Test Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Test Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Test Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Test Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Test Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Test Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Test Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Test Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Test Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Test Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Test Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Test Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Test Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Test Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Atlas Medical GmbH
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Church And Dwight Co., Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Everlywell, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Geratherm Medical AG
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. QuidelOrtho Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Mylab Discovery Solutions Pvt. Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Salignostics
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Abbott
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. SPD Swiss Precision Diagnostics GmbH
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. AdvaCare Pharma
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments